3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Breast Neoplasms
2
Vomiting
1
Uterine Cervical Neoplasms
1
Trigger Finger Disorder
1
Sarcoma, Alveolar Soft Part
1
Renal Insufficiency
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Pain
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nausea
1
Mucositis
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Mast-Cell
1
Leukemia, Hairy Cell
1
Interventions
aldesleukin
22
Sunitinib
21
Bevacizumab
16
Interleukin-2
14
Everolimus
14
Interferon-alpha
13
Gemcitabine
13
Cyclophosphamide
13
fludarabine phosphate
11
Peripheral Blood Stem Cell Transplantation
9
Sorafenib
8
Filgrastim
8
Axitinib
8
Nivolumab
7
pembrolizumab
6
Ipilimumab
6
Doxorubicin
6
Carboplatin
6
sargramostim
5
cabozantinib
5
Capecitabine
5
Thalidomide
4
Tacrolimus
4
Radiotherapy
4
Radiosurgery
4
Neoadjuvant Therapy
4
Mycophenolic Acid
4
Magnetic Resonance Spectroscopy
4
Erlotinib Hydrochloride
4
Chemotherapy, Adjuvant
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Kidney Neoplasms
×
Acetaminophen
×
Clear all
NCT05842044
2025-09-05
No-PAIN
University of Miami
Phase 2
Recruiting
110 enrolled